Roberto Cattaneo

Mayo Clinic in Arizona — United States

Medicine · Health Sciences

86h-index22.6kcitations437works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virology and Viral Diseases(182), Virus-based gene therapy research(113), Respiratory viral infections research(67), Systemic Lupus Erythematosus Research(58), Viral Infections and Immunology Research(41)

Publications431 total

Measles virus: how it works
˜The œbiomedical & life sciences collection.·2026Open Access
Mitochondrial targeting by measles virus nucleoprotein modulates viral spread in human airway epithelium
PLoS Pathogens·2025Open Access
Trafficking and Activation of Henipavirus, Parahenipavirus, and Henipa-like Virus Fusion Proteins
Viruses·2025Open Access
Measles vaccine attenuation comprises innate immune cell infection and interferon responses
2025
The measles virus matrix F50S mutation from a lethal case of subacute sclerosing panencephalitis promotes receptor-independent neuronal spread
Journal of Virology·2024· 3 citedOpen Access
A measles virus collective infectious unit that caused lethal human brain disease includes many locally restricted and few widespread copy-back defective genomes
Journal of Virology·2024· 5 citedOpen Access
From pandemic to endemic: Divergence of COVID-19 positive-tests and hospitalization numbers from SARS-CoV-2 RNA levels in wastewater of Rochester, Minnesota
Heliyon·2024· 2 citedOpen Access
Brain tropism acquisition: The spatial dynamics and evolution of a measles virus collective infectious unit that drove lethal subacute sclerosing panencephalitis
PLoS Pathogens·2023· 18 citedOpen Access
Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells
Microbiology Spectrum·2023· 6 citedOpen Access
Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023Open Access
Supplementary Figure 1 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Figure 6 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Methods and Materials from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Figure 6 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Figure 3 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Methods and Materials from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Data from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023Open Access
Supplementary Figure 4 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Supplementary Tables 1-4 from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
Data from Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Martin Billeter(12), K. Baczko(7), Volker ter Meulen(7), Veronika von Messling(6), Stephen J. Russell(6), Anita Schmid(5), Maria Giovanna Danieli(4), Kah-Whye Peng(4), Hans Will(4), Heinz Schaller(4), Anǵela Tincani(4), Frédéric Houssiau(3), Carlos Vasconcelos(3), Gian Domenico Sebastiani(3), Enrique de Ramón Garrido(3), Daniel Abramovicz(3), Daniël Blockmans(3), Haner Di̇reskeneli̇(3), Ahmet Gül(3), Yair Levy(3)